John D. Imig

16.1k total citations · 2 hit papers
255 papers, 13.3k citations indexed

About

John D. Imig is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John D. Imig has authored 255 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Biochemistry, 139 papers in Endocrinology, Diabetes and Metabolism and 93 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John D. Imig's work include Eicosanoids and Hypertension Pharmacology (168 papers), Hormonal Regulation and Hypertension (131 papers) and Nitric Oxide and Endothelin Effects (67 papers). John D. Imig is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (168 papers), Hormonal Regulation and Hypertension (131 papers) and Nitric Oxide and Endothelin Effects (67 papers). John D. Imig collaborates with scholars based in United States, Czechia and Germany. John D. Imig's co-authors include Bruce D. Hammock, Edward W. Inscho, L. Gabriel Navar, John R. Falck, Xueying Zhao, David M. Pollock, R. J. Roman, Jorge H. Capdevila, Ahmed A. Elmarakby and Abdul H. Khan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

John D. Imig

251 papers receiving 13.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Paracrine regulation of the renal microcirculation

1996 613 citations L. Gabriel Navar, Edward W. Inscho et al. profile →
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases

2009 507 citations John D. Imig, Bruce D. Hammock profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
John D. Imig	7.1k	5.9k	3.7k	3.0k	2.6k	255	13.3k
Richard J. Roman	4.9k 0.7×	2.9k 0.5×	1.4k 0.4×	2.7k 0.9×	1.6k 0.6×	130	8.3k
Michal L. Schwartzman	5.8k 0.8×	2.9k 0.5×	1.1k 0.3×	1.9k 0.7×	4.5k 1.7×	258	11.2k
Matthew D. Breyer	3.2k 0.4×	2.8k 0.5×	1.9k 0.5×	2.6k 0.9×	6.6k 2.5×	204	16.0k
Neal L. Weintraub	2.3k 0.3×	1.4k 0.2×	3.0k 0.8×	2.5k 0.9×	3.7k 1.4×	268	11.9k
Beate Fißlthaler	3.2k 0.5×	2.1k 0.4×	2.1k 0.6×	4.2k 1.4×	4.0k 1.5×	82	10.8k
Jorge H. Capdevila	7.7k 1.1×	4.0k 0.7×	693 0.2×	1.6k 0.5×	2.9k 1.1×	199	11.5k
Richard J. Roman	1.5k 0.2×	2.1k 0.3×	1.9k 0.5×	1.6k 0.6×	2.0k 0.8×	229	7.6k
R. J. Roman	2.6k 0.4×	1.7k 0.3×	1.3k 0.4×	2.0k 0.7×	1.0k 0.4×	70	5.0k
Tianxin Yang	1.2k 0.2×	2.0k 0.3×	1.8k 0.5×	1.4k 0.5×	3.4k 1.3×	170	7.9k
Alberto Nasjletti	1.8k 0.3×	1.5k 0.3×	2.1k 0.6×	1.8k 0.6×	3.0k 1.2×	183	7.1k

Countries citing papers authored by John D. Imig

Since Specialization

Citations

This map shows the geographic impact of John D. Imig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Imig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Imig more than expected).

Fields of papers citing papers by John D. Imig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Imig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Imig. The network helps show where John D. Imig may publish in the future.

Co-authorship network of co-authors of John D. Imig

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Imig. A scholar is included among the top collaborators of John D. Imig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Imig. John D. Imig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Mishra, Abhishek, et al.. (2025). Synthetic Epoxyeicosatrienoic Acid Mimics Protect Mesangial Cells from Sorafenib-Induced Cell Death. Molecules. 30(7). 1445–1445.

2.

Husková, Zuzana, Janusz Sadowski, Lenka Hošková, et al.. (2024). Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats. Hypertension Research. 47(11). 3126–3146. 1 indexed citations

3.

Goorani, Samaneh, et al.. (2024). Hypertension: A Continuing Public Healthcare Issue. International Journal of Molecular Sciences. 26(1). 123–123. 6 indexed citations

4.

Imig, John D.. (2023). Bioactive lipids in hypertension. Advances in pharmacology. 97. 1–35. 2 indexed citations

5.

Imig, John D.. (2023). Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension. Frontiers in Physiology. 14. 1186477–1186477.

6.

Imig, John D., et al.. (2023). Salt-sensitive hypertension after reversal of unilateral ureteral obstruction. Biochemical Pharmacology. 210. 115438–115438. 3 indexed citations

7.

Hwang, Sung Hee, et al.. (2021). Multitarget molecule, PTUPB, to treat diabetic nephropathy in rats. British Journal of Pharmacology. 178(22). 4468–4484. 8 indexed citations

8.

Zhang, Yuanyuan, et al.. (2021). Tim-1 Deficiency Aggravates High-Fat Diet-Induced Steatohepatitis in Mice. Frontiers in Immunology. 12. 747794–747794. 4 indexed citations

9.

Barnett, Scott D., et al.. (2021). Dual sEH/COX-2 Inhibition Using PTUPB—A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity. Frontiers in Pharmacology. 12. 744776–744776. 6 indexed citations

10.

Melenovský, Vojtěch, František Kolář, John D. Imig, et al.. (2019). Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure. Kidney & Blood Pressure Research. 44(4). 792–809. 16 indexed citations

11.

Imig, John D. & Abdul H. Khan. (2016). Cytochrome P450 and Lipoxygenase Metabolites on Renal Function. Comprehensive physiology. 6(1). 423–441. 1 indexed citations

12.

Imig, John D. & Abdul H. Khan. (2015). Cytochrome P450 and Lipoxygenase Metabolites on Renal Function. Comprehensive physiology. 6(1). 423–441. 23 indexed citations

13.

Imig, John D. & Michael J. Ryan. (2013). Immune and Inflammatory Role in Renal Disease. Comprehensive physiology. 3(2). 957–976. 11 indexed citations

14.

Gauthier, Kathryn M., Marilyn A. Isbell, John D. Imig, et al.. (2011). Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles. American Journal of Physiology-Renal Physiology. 301(4). F765–F772. 3 indexed citations

15.

Simpkins, Alexis N., R. Daniel Rudic, Derek A. Schreihofer, et al.. (2009). Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection. American Journal Of Pathology. 174(6). 2086–2095. 99 indexed citations

16.

Chen, Jian‐Kang, Jianchun Chen, John D. Imig, et al.. (2008). Identification of Novel Endogenous Cytochrome P450 Arachidonate Metabolites with High Affinity for Cannabinoid Receptors. Journal of Biological Chemistry. 283(36). 24514–24524. 66 indexed citations

17.

Inscho, Edward W., John D. Imig, Anthony K. Cook, & David M. Pollock. (2005). ET_A and ET_B receptors differentially modulate afferent and efferent arteriolar responses to endothelin. British Journal of Pharmacology. 146(7). 1019–1026. 79 indexed citations

18.

Inscho, Edward W., Anthony K. Cook, John D. Imig, Catherine Vial, & Richard J. Evans. (2003). Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. Journal of Clinical Investigation. 112(12). 1895–1905. 61 indexed citations

19.

Inscho, Edward W., Anthony K. Cook, John D. Imig, Catherine Vial, & Richard J. Evans. (2003). Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. Journal of Clinical Investigation. 112(12). 1895–1905. 141 indexed citations

20.

Navar, L. Gabriel, et al.. (1998). Heterogeneous activation mechanisms in the renal microvasculature. Kidney International. 54. S17–S21. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact